帕金森病中的基因表达不对称:CCT基因表达的变异与半球特定严重程度相关
Steven E Pierce1, Edwin J C van der Schans1, Thomas M Goralski1
1Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Frontiers in molecular neuroscience
|January 29, 2026
概括
帕金森病 (PD) 呈现出半球差异. 大脑半球中CCT基因的表达水平与症状严重程度相关,这表明CCT在PD中起着保护作用.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 经常表现出单边症状,暗示大脑半球之间的分子差异.
- 了解半球脆弱性是解开PD病变的关键.
研究的目的:
- 为了研究帕金森病中半球基因表达差异.
- 为了确定PD中单边症状发作的分子相关性.
主要方法:
- 从PD患者和对照组中双边前额叶皮层取样.
- 在神经元核上进行RNA测序,以分析基因表达.
- 根据基因表达特征对PD患者的分层.
主要成果:
- 在PD和对照半球之间观察到显著的基因表达变异.
- 对于PD患者的一个子集,半球CCT基因表达与症状发作的侧面相关.
- 在具有α-synuclein含量的小鼠模型中观察到CCT表达的减少.
结论:
- 在帕金森病中,CCT基因表达表现出半球不对称.
- CCT可能起到防止PD进展的保护作用.
- 基因表达分层对于识别PD相关的遗传不对称性至关重要.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...


